Department of Cardiovascular Surgery, Nihon University School of Medicine, 30-1 Ooyaguchi-kami-machi, Itabashi-ku, Tokyo, 173-8610, Japan.
Surg Today. 2013 Mar;43(3):264-70. doi: 10.1007/s00595-012-0322-6. Epub 2012 Sep 4.
Postcardiotomy cardiogenic shock is still associated with a poor prognosis. We reviewed patients undergoing extracorporeal membrane oxygenation (ECMO) support for postcardiotomy cardiogenic shock and assessed their long-term outcomes.
The subjects were 47 patients who received ECMO support for cardiogenic shock after open heart surgery. We analyzed the long-term survival and risk factors for early or late death.
Twenty-nine patients were weaned off ECMO support, but 15 of these patients died during their hospital stay. An independent predictor of mortality during ECMO support was incomplete sternum closure (OR 4.089, 95 % CL 1.003-16.67, p = 0.049) and a predictor of mortality after weaning off ECMO was more than 48 h of support (OR 8.975, 95 % CL 1.281-62.896, p = 0.027). Fourteen patients were discharged from hospital, but seven of these patients died during the follow-up period owing to cardiac events (n = 2) or non-cardiac causes (n = 5). The actuarial survival rates were 34.0 % at 30 days, 29.8 % at 1 year, and 17.6 % at 10 years.
Although postcardiotomy cardiogenic shock requiring ECMO support is associated with high morbidity and mortality, the long-term survival rate is acceptable.
心脏手术后并发心原性休克仍然与预后不良相关。我们回顾了接受体外膜肺氧合(ECMO)支持治疗心脏手术后心原性休克的患者,并评估了他们的长期结局。
本研究对象为 47 例因开胸手术后心原性休克而接受 ECMO 支持的患者。我们分析了长期生存情况以及早期和晚期死亡的危险因素。
29 例患者成功撤离 ECMO 支持,但其中 15 例患者在住院期间死亡。ECMO 支持期间死亡的独立预测因素是胸骨不完全闭合(OR 4.089,95%CL 1.003-16.67,p=0.049),撤离 ECMO 后死亡的预测因素是支持时间超过 48 小时(OR 8.975,95%CL 1.281-62.896,p=0.027)。14 例患者出院,但由于心脏事件(n=2)或非心脏原因(n=5),在随访期间有 7 例患者死亡。30 天、1 年和 10 年的累计生存率分别为 34.0%、29.8%和 17.6%。
尽管需要 ECMO 支持的心脏手术后心原性休克与高发病率和死亡率相关,但长期生存率是可以接受的。